Biblio

Found 1 results

Filters: Keyword is Antibodies, Monoclonal and Author is Saba, Nabil F [Clear All Filters]

2023

Bauman JE, Saba NF, Roe D, Bauman JR, Kaczmar J, Bhatia A, Muzaffar J, Julian R, Wang S, Bearelly S et al.. 2023. Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.. J Clin Oncol. 41(22):3851-3862.